Xin Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xin Huang has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Bhushan Sandeep
Department of Cardio-Thoracic Surgery, West China School of Medicine, Sichuan University, Sichuan University affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital, Chengdu
15 shared publications - Jing Yang
Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China
7 shared publications - Zongwei Xiao
Department of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan, 610017, China
5 shared publications Bhushan Sandeep
Department of Cardio-Thoracic Surgery, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People’s Hospital, Chengdu Second People’s Hospital
3 shared publications- Dan Xiong
Department of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan, 610017, China
3 shared publications Chengdu Second People'S Hospital.
2 shared publications
Latest Publications
- Open Access
- 24 August 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1871492
The impact of remimazolam on postoperative neurocognitive disorder in elderly surgical patients: a systematic review and meta-analysis
Background: Postoperative neurocognitive disorder (PND), including postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), are prevalent and debilitating complications in elderly surgical patients. Remimazolam, a novel ultra-short-acting benzodiazepine with favorable hemodynamic and sedative properties, has not been fully evaluated for its impact on PND. Method: This systematic review and meta-analysis included studies retrieved from PubMed, Embase, Web of Science, and Cochrane library up to February 2026. Eligible studies compared remimazolam with other sedatives in elderly surgical patients and reported POD or POCD incidence. The primary outcome was the incidence of POD/POCD; secondary outcomes included postoperative MMSE scores, intraoperative opioids consumption, duration of post-anesthesia care unit (PACU) and hospital stay, and perioperative complications. Results: Fifteen randomized controlled trials (RCTs) involving 2,226 patients were analyzed. Remimazolam was not statistically associated with reduction in POD incidence on postoperative days 1 or 3, nor did it affect delirium subtypes or duration. However, remimazolam may be associated with a reduced risk of early POCD on days 1, 3, and 5. Remimazolam reduced intraoperative remifentanil consumption and the incidence of perioperative hemodynamic complications (hypotension and bradycardia). MMSE scores were higher on day 7, and no statistically significant differences were observed in postoperative nausea and vomiting, PACU stay, or hospital stay duration. Conclusion: Remimazolam was not associated with a reduction in POD incidence but may offer a protective effect against early POCD in elderly surgical patients. It provides a favorable hemodynamic profile, and its opioid-sparing properties indicate that it may be a viable sedative option in this population, though further well-designed trials are required. Systematic Review Registration: https://inplasy.com/inplasy-2026-4-0037/ .
- 24 August 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1871492
Open AccessThe impact of remimazolam on postoperative neurocognitive disorder in elderly surgical patients: a systematic review and meta-analysis
Background: Postoperative neurocognitive disorder (PND), including postoperative delirium (POD) and postoperative cognitive dysfunction (POCD), are prevalent and debilitating complications in elderly surgical patients. Remimazolam, a novel ultra-short-acting benzodiazepine with favorable hemodynamic and sedative properties, has not been fully evaluated for its impact on PND. Method: This systematic review and meta-analysis included studies retrieved from PubMed, Embase, Web of Science, and Cochrane library up to February 2026. Eligible studies compared remimazolam with other sedatives in elderly surgical patients and reported POD or POCD incidence. The primary outcome was the incidence of POD/POCD; secondary outcomes included postoperative MMSE scores, intraoperative opioids consumption, duration of post-anesthesia care unit (PACU) and hospital stay, and perioperative complications. Results: Fifteen randomized controlled trials (RCTs) involving 2,226 patients were analyzed. Remimazolam was not statistically associated with reduction in POD incidence on postoperative days 1 or 3, nor did it affect delirium subtypes or duration. However, remimazolam may be associated with a reduced risk of early POCD on days 1, 3, and 5. Remimazolam reduced intraoperative remifentanil consumption and the incidence of perioperative hemodynamic complications (hypotension and bradycardia). MMSE scores were higher on day 7, and no statistically significant differences were observed in postoperative nausea and vomiting, PACU stay, or hospital stay duration. Conclusion: Remimazolam was not associated with a reduction in POD incidence but may offer a protective effect against early POCD in elderly surgical patients. It provides a favorable hemodynamic profile, and its opioid-sparing properties indicate that it may be a viable sedative option in this population, though further well-designed trials are required. Systematic Review Registration: https://inplasy.com/inplasy-2026-4-0037/ .
- 18 July 2026
- Published by Elsevier in Current Problems in Cardiology
- Vol. 51 (10) , 103398
Observational analyses in cardiovascular device evaluation, methods, applications, and challenges: A comprehensive review
- 18 July 2026
- Published by Elsevier in Current Problems in Cardiology
- Vol. 51 (10) , 103398
Observational analyses in cardiovascular device evaluation, methods, applications, and challenges: A comprehensive review
- Open Access
- 7 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (3) , e70809
Intraoperative 40 Hz Visual Light Flicker Attenuates Anesthesia/Surgery‐Induced Cognitive Impairments in Elderly Mice With Enhanced Cortical‐Hippocampal Coherence
Background: Forty Hz light flicker has shown promise in mitigating cognitive impairments, though its mechanisms remain unclear. Aims: This study aimed to use perioperative neurocognitive dysfunction (PND) as a unique model of neural damage to provide a broader understanding of the neural mechanisms underlying the cognitive improvements associated with 40 Hz visual stimulation and offer new insights into the clinical application of PND treatment. Materials and Methods: Postoperative cognitive function was assessed through behavioral tests. Male and female mice received various visual light flicker stimuli, including 40 Hz, random, continuous, or no light. Local field potentials were recorded from the hippocampal dentate gyrus (DG) and primary visual cortex. Results: Our results show that among the stimuli, only the 40 Hz flicker improved cognitive function, impaired by anesthesia or surgery. Intraoperative 40 Hz stimulation activated the primary visual cortex and was correlated with enhanced gamma coherence between this region and the hippocampal DG, a coherence that surgery itself notably reduced. This preserved functional connectivity. Additionally, hippocampal DG activity was enhanced, particularly in the gamma frequency range. Conclusion: Our results suggest that 40 Hz flicker mitigates anesthesia/surgery‐induced cognitive deficits, potentially through modulating gamma coherence between the visual cortex and hippocampus. These findings provide insights into PND prevention and the neural mechanisms underlying 40 Hz‐induced cognitive benefits.
- 7 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (3) , e70809
Open AccessIntraoperative 40 Hz Visual Light Flicker Attenuates Anesthesia/Surgery‐Induced Cognitive Impairments in Elderly Mice With Enhanced Cortical‐Hippocampal Coherence
Background: Forty Hz light flicker has shown promise in mitigating cognitive impairments, though its mechanisms remain unclear. Aims: This study aimed to use perioperative neurocognitive dysfunction (PND) as a unique model of neural damage to provide a broader understanding of the neural mechanisms underlying the cognitive improvements associated with 40 Hz visual stimulation and offer new insights into the clinical application of PND treatment. Materials and Methods: Postoperative cognitive function was assessed through behavioral tests. Male and female mice received various visual light flicker stimuli, including 40 Hz, random, continuous, or no light. Local field potentials were recorded from the hippocampal dentate gyrus (DG) and primary visual cortex. Results: Our results show that among the stimuli, only the 40 Hz flicker improved cognitive function, impaired by anesthesia or surgery. Intraoperative 40 Hz stimulation activated the primary visual cortex and was correlated with enhanced gamma coherence between this region and the hippocampal DG, a coherence that surgery itself notably reduced. This preserved functional connectivity. Additionally, hippocampal DG activity was enhanced, particularly in the gamma frequency range. Conclusion: Our results suggest that 40 Hz flicker mitigates anesthesia/surgery‐induced cognitive deficits, potentially through modulating gamma coherence between the visual cortex and hippocampus. These findings provide insights into PND prevention and the neural mechanisms underlying 40 Hz‐induced cognitive benefits.
- Open Access
- 12 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (4) , 2393-2394
Current status and prospects of ciprofol in clinical anesthesia: A bibliometric analysis
- 12 November 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (4) , 2393-2394
Open AccessCurrent status and prospects of ciprofol in clinical anesthesia: A bibliometric analysis
- Open Access
- 28 September 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (3) , 1912-1913
Efficacy of stellate ganglion block on postoperative sleep disorder: A systematic review
- 28 September 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (3) , 1912-1913
Open AccessEfficacy of stellate ganglion block on postoperative sleep disorder: A systematic review
- 16 March 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (5) , 102528
The impact of frailty as a critical mediator causing postoperative neurocognitive disorders in postoperative cardiac patients
- 16 March 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (5) , 102528
The impact of frailty as a critical mediator causing postoperative neurocognitive disorders in postoperative cardiac patients
- 16 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102464
Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure
- 16 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102464
Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure
- 2 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102425
Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy
- 2 February 2024
- Published by Elsevier in Current Problems in Cardiology
- Vol. 49 (4) , 102425
Right ventricle-pulmonary artery coupling in pulmonary artery hypertension its measurement and pharmacotherapy
- Open Access
- 23 January 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (5) , 2359-2360
Progress in the use of anticholinergic drugs during perioperative period
- 23 January 2024
- Published by Elsevier in Asian Journal of Surgery
- Vol. 47 (5) , 2359-2360
Open AccessProgress in the use of anticholinergic drugs during perioperative period